RECENT NEWS AND ANNOUNCEMENTS IN DR-TB
Why is a curable disease allowed to kill millions?
International consensus highlights the importance of molecular testing for MDR-TB
Sweet advance for treatment of children with multi-drug resistant TB
New safer and shorter drug-resistant TB treatment must be scaled up
MSF applauds Indian Patent Office’s rejection of J&J’s attempt to extend patent on lifesaving
World TB Day 2023 Campaign Toolkit
Sutezolid with 3-drug combo appears safe and effective in multidrug-resistant TB
TAG's TB Treatment Pipeline Report Published
Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short
Undernutrition linked to increased mortality in multidrug-resistant TB
Urgent action necessary to improve equitable access to bedaquiline-based regiments and achieve 1/4/6
2022 Updates to Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, 3rd ed.
WHO announces landmark changes in treatment of drug-resistant TB!
Price reduction paves the way for expanded access to highly effective MDR-TB
Public Health Leaders, Researchers, and Activists Launch Campaign to Revolutionize Tuberculosis
New testing method could make TB diagnosis easier
Drug-Resistant TB Trial Results Published in New England Journal of Medicine
MSF warns that supply delays of critical TB test will cost lives
1 / 4 / 6 x 24 Campaign launched to rally energy, political will, funding needed to fight TB
PAN-TB collaboration to advance investigational TB drug regimens to Phase 2 clinical trials